These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 15064711

  • 1. A cytoskeleton-based functional genetic screen identifies Bcl-xL as an enhancer of metastasis, but not primary tumor growth.
    Martin SS, Ridgeway AG, Pinkas J, Lu Y, Reginato MJ, Koh EY, Michelman M, Daley GQ, Brugge JS, Leder P.
    Oncogene; 2004 Jun 03; 23(26):4641-5. PubMed ID: 15064711
    [Abstract] [Full Text] [Related]

  • 2. Human MCF10A mammary epithelial cells undergo apoptosis following actin depolymerization that is independent of attachment and rescued by Bcl-2.
    Martin SS, Leder P.
    Mol Cell Biol; 2001 Oct 03; 21(19):6529-36. PubMed ID: 11533241
    [Abstract] [Full Text] [Related]

  • 3. Bcl-2-mediated cell survival promotes metastasis of EpH4 betaMEKDD mammary epithelial cells.
    Pinkas J, Martin SS, Leder P.
    Mol Cancer Res; 2004 Oct 03; 2(10):551-6. PubMed ID: 15498929
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis.
    España L, Fernández Y, Rubio N, Torregrosa A, Blanco J, Sierra A.
    Breast Cancer Res Treat; 2004 Sep 03; 87(1):33-44. PubMed ID: 15377849
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents.
    Fan S, Wang JA, Yuan RQ, Rockwell S, Andres J, Zlatapolskiy A, Goldberg ID, Rosen EM.
    Oncogene; 1998 Jul 16; 17(2):131-41. PubMed ID: 9674697
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of apoptosis in human breast cancer cells: role in tumor progression to the metastatic state.
    Fernández Y, Gu B, Martínez A, Torregrosa A, Sierra A.
    Int J Cancer; 2002 Oct 01; 101(4):317-26. PubMed ID: 12209955
    [Abstract] [Full Text] [Related]

  • 8. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
    Wang Z, Goulet R, Stanton KJ, Sadaria M, Nakshatri H.
    Anticancer Res; 2005 Oct 01; 25(3c):2367-79. PubMed ID: 16080463
    [Abstract] [Full Text] [Related]

  • 9. Anti-apoptotic proteins induce non-random genetic alterations that result in selecting breast cancer metastatic cells.
    Méndez O, Fernández Y, Peinado MA, Moreno V, Sierra A.
    Clin Exp Metastasis; 2005 Oct 01; 22(4):297-307. PubMed ID: 16170666
    [Abstract] [Full Text] [Related]

  • 10. Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells.
    Majumder B, Wahle KW, Moir S, Schofield A, Choe SN, Farquharson A, Grant I, Heys SD.
    FASEB J; 2002 Sep 01; 16(11):1447-9. PubMed ID: 12205043
    [Abstract] [Full Text] [Related]

  • 11. Combined targeted inhibition of bcl-2, bcl-XL, epidermal growth factor receptor, and protein kinase A type I causes potent antitumor, apoptotic, and antiangiogenic activity.
    Tortora G, Caputo R, Damiano V, Caputo R, Troiani T, Veneziani BM, De Placido S, Bianco AR, Zangemeister-Wittke U, Ciardiello F.
    Clin Cancer Res; 2003 Feb 01; 9(2):866-71. PubMed ID: 12576461
    [Abstract] [Full Text] [Related]

  • 12. MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition.
    Pinkas J, Leder P.
    Cancer Res; 2002 Aug 15; 62(16):4781-90. PubMed ID: 12183438
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased Bcl-xL expression mediates v-Src-induced resistance to anoikis in intestinal epithelial cells.
    Coll ML, Rosen K, Ladeda V, Filmus J.
    Oncogene; 2002 Apr 25; 21(18):2908-13. PubMed ID: 11973652
    [Abstract] [Full Text] [Related]

  • 15. Bcl-XL protects cancer cells from p53-mediated apoptosis.
    Schott AF, Apel IJ, Nuñez G, Clarke MF.
    Oncogene; 1995 Oct 05; 11(7):1389-94. PubMed ID: 7478561
    [Abstract] [Full Text] [Related]

  • 16. [Screening of a sub-clone of human breast cancer cells with high metastasis potential].
    Ye LH, Wu LY, Guo W, Ma HT, Zhang XD.
    Zhonghua Yi Xue Za Zhi; 2006 Jan 03; 86(1):61-5. PubMed ID: 16606541
    [Abstract] [Full Text] [Related]

  • 17. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells.
    Real PJ, Sierra A, De Juan A, Segovia JC, Lopez-Vega JM, Fernandez-Luna JL.
    Oncogene; 2002 Oct 31; 21(50):7611-8. PubMed ID: 12400004
    [Abstract] [Full Text] [Related]

  • 18. N'-((2-(6-bromo-2-oxo-2H-chromen-3-yl)-1H-indol-3-yl)methylene)benzohydrazide as a probable Bcl-2/Bcl-xL inhibitor with apoptotic and anti-metastatic potential.
    Kamath PR, Sunil D, Ajees AA, Pai KS, Biswas S.
    Eur J Med Chem; 2016 Sep 14; 120():134-47. PubMed ID: 27187865
    [Abstract] [Full Text] [Related]

  • 19. Suppression activity of pro-apoptotic gene products in cancer cells, a potential application for cancer gene therapy.
    Lin J, Page C, Jin X, Sethi AO, Patel R, Nunez G.
    Anticancer Res; 2001 Sep 14; 21(2A):831-9. PubMed ID: 11396172
    [Abstract] [Full Text] [Related]

  • 20. The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation.
    Schmitt E, Sané AT, Steyaert A, Cimoli G, Bertrand R.
    Biochem Cell Biol; 1997 Sep 14; 75(4):301-14. PubMed ID: 9493953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.